SACHDEV AMIT (EVP, CRO) received a stock award from VERTEX PHARMACEUTICALS INC / MA
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/19/2026ACC: 0000875320-26-000096
Officer· EVP, CRO
Since Jun 2018
+3.65K
Net shares
Net buyer
$1.04M
Total sold
0
Open market trades
0B · 0S
2
Total transactions
5.79K acquired · 2.14K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5.79K
Price / share
—
Trade value
—
% of position
8.9%
2/17/2026
65.39K→71.18K
Common Stock
Direct
Shares
−2.14K
Price / share
$483.75
Trade value
$1.04M
% of position
3.0%
2/17/2026
71.18K→69.04K
Total
Net shares
+3.65K
Net value
-$1.04M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/17/2026 | A · Award | +5.79K | — | — | 8.9% | 65.39K | 71.18K |
| Common Stock Direct | 2/17/2026 | F · Tax Withholding | −2.14K | $483.75 | $1.04M | 3.0% | 71.18K | 69.04K |
| Total | +3.65K | -$1.04M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned9.30K
Common Stock
IndirectShares owned882.00
Total
10.18K indirect10.18K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 9.30K | Indirect |
| Common Stock | 882.00 | Indirect |
| Total | 10.18K | 10.18K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported